---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-036441"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T10:51:37.776166+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma elects two Class I directors, ratifies Marcum as auditor at 2024 annual meeting

## Summary
- Elected Damon DeSantis as Class I director: 20,448,871 for, 142,036 withheld, 1,342,353 broker non-votes.
- Elected Riva Sheppard as Class I director: 20,301,671 for, 289,236 withheld, 1,342,353 broker non-votes.
- Ratified appointment of Marcum LLP as independent auditor for FY2025: 21,905,273 for, 9,287 against, 18,700 abstain.
- Total shares voted: 21,933,260 of 30,099,610 entitled; quorum present.

## SEC filing metadata
- accession: 0001437749-24-036441
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/0001437749-24-036441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/inbp20241202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-036441
- JSON: https://secwatch.observer/filing/0001437749-24-036441.json
- Plain text: https://secwatch.observer/filing/0001437749-24-036441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.